Time: 2024-07-14
A study published in the journal Science Translational Medicine has revealed that Long COVID patients exhibit abnormal immune cell activation and carry remaining SARS - CoV-2 RNA in their gut . The persistence of the virus and sustained immune activation are believed to be significant factors contributing to long COVID symptoms . Common long COVID symptoms include fatigue , shortness of breath , brain fog , and heart disease , impacting an estimated 18 million adults in the US.
Researchers from the University of California San Francisco conducted PET scans on 24 recovered COVID-19 patients , ranging from 27 to 910 days post - infection , to explore the biological basis of long COVID . The imaging showed activated T cells in regions such as the brain , spinal cord , gut , and lung tissues , correlating with long COVID symptoms like persistent pulmonary issues . The study identified intracellular SARS - CoV-2 RNA in the gut of patients with long COVID , even up to 676 days after the initial infection , highlighting the potential association between tissue viral persistence and long - term immune disruptions.
The research team at the University of California San Francisco and CellSight Technologies found that some long COVID patients display unusual immune cell activity in various organs , along with traces of SARS - CoV-2 RNA in their guts up to two years post - infection . PET scans conducted on the patients showed increased T cell activation in tissues throughout the body . Abnormal T cell activity was observed in areas corresponding to reported symptoms , such as brain fog , indicating a connection between immune responses and specific long COVID manifestations.
The findings from both studies shed light on the biological underpinnings of long COVID , emphasizing the persistence of the virus and immune activation as critical factors in the condition . Understanding how SARS - CoV-2 lingers in the body and triggers abnormal immune responses could pave the way for targeted treatments for long COVID . Further research with larger cohorts is needed to elucidate the relationships between tissue - level immune responses and specific long COVID symptoms , offering hope for improved management and intervention strategies in the future.